Adams Express Company increased Unitedhealth Group Incorporated (UNH) stake by 286.67% reported in 2018Q1 SEC filing. Adams Express Company acquired 120,400 shares as Unitedhealth Group Incorporated (UNH)’s stock rose 4.65%. The Adams Express Company holds 162,400 shares with $34.75M value, up from 42,000 last quarter. Unitedhealth Group Incorporated now has $241.84 billion valuation. The stock decreased 0.09% or $0.23 during the last trading session, reaching $251.66. About 116,472 shares traded. UnitedHealth Group Incorporated (NYSE:UNH) has risen 37.57% since June 22, 2017 and is uptrending. It has outperformed by 25.00% the S&P500. Some Historical UNH News: 05/04/2018 – Ascensia Diabetes Care Announces Expanded Access to Contour®Next Meters and Test Strips for Unitedhealthcare Members With Diabetes; 17/04/2018 – UnitedHealth 1Q Rev $55.19B; 17/04/2018 – UnitedHealth 1Q Optum Revenue $23.6B; 02/04/2018 – Shares of Anthem, UnitedHealth and Medicaid-provider Centene rise in premarket trading after sources confirm early deals talks between Walmart and Humana; 30/05/2018 – UnitedHealth at AllianceBernstein Conference Tomorrow; 03/05/2018 – Construction Begins for The Elisabetta, a New Community That Will Bring High-Quality, Affordable Housing to the Globeville; 17/04/2018 – UNITEDHEALTH 1Q REV. $55.2B, EST. $54.87B; 02/04/2018 – QUEST – CO, HUMANA, MULTIPLAN, UNITEDHEALTH GROUP’S OPTUM, UNITEDHEALTHCARE LAUNCH BLOCKCHAIN PROGRAM TO IMPROVE DATA QUALITY AMONG OTHERS; 10/05/2018 – Envision Healthcare: In Arbitration With a UnitedHealth Group Unit, Alleges United Breached Medical Group Participation Agreement; 13/03/2018 – Top 3– #1 From drugmaker to drug manager: Ex-GSK chief Andrew Witty jumps to the helm of giant Optum $GSK $UNH
Greenwood Gearhart Inc increased Novartis Ag (NVS) stake by 9.3% reported in 2018Q1 SEC filing. Greenwood Gearhart Inc acquired 4,924 shares as Novartis Ag (NVS)’s stock declined 11.54%. The Greenwood Gearhart Inc holds 57,885 shares with $4.68 million value, up from 52,961 last quarter. Novartis Ag now has $193.13B valuation. The stock increased 1.16% or $0.86 during the last trading session, reaching $74.84. About 116,883 shares traded. Novartis AG (NYSE:NVS) has declined 6.45% since June 22, 2017 and is downtrending. It has underperformed by 19.02% the S&P500. Some Historical NVS News: 10/04/2018 – AveXis sells on Novartis approach, source says [23:13 BST10 Apr 2018] [Proprietary] ; 09/04/2018 – NOVARTIS EXECUTIVE MAKES COMMENT ON DEAL CALL; 27/03/2018 – GLAXOSMITHKLINE PLC – GSK HAS ENTERED INTO A COMMITTED FACILITIES AGREEMENT TO SUPPORT FUNDING OF BUYOUT; 19/04/2018 – Novartis poaches Bristol-Myers/Amgen vet John Tsai for top drug development post in a $9B organization $NVS $AMGN; 16/05/2018 – NOVARTIS AG NOVN.S SAYS ALCON RETURNING TO A POSITION OF STRENGTH AS WORLD’S LEADING EYE CARE DEVICES COMPANY; 27/03/2018 – $GSK to buy stake in consumer healthcare joint venture from $NVS for $13B after pulling out of $20B race for $PFE’s consumer health care unit; 16/05/2018 – NOVARTIS AG NOVN.S CEO SAYS HOPES TO HAVE AIMOVIG APPROVAL IN COMING WEEKS, HOPES TO BE FIRST TO MARKET WITH MIGRAINE MEDICINE; 17/04/2018 – Novartis tender offer for AveXis commences; 19/04/2018 – Novartis delivered a strong first quarter and acted to become a more focused medicines company; 27/03/2018 – GSK buys Novartis stake in consumer health care venture for $13 billion
Among 17 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 3 Sell and 9 Hold. Therefore 29% are positive. Novartis Ag had 38 analyst reports since July 28, 2015 according to SRatingsIntel. Morgan Stanley downgraded the shares of NVS in report on Tuesday, April 12 to “Underperform” rating. On Wednesday, July 5 the stock rating was downgraded by Credit Suisse to “Underperform”. The firm earned “Buy” rating on Wednesday, March 8 by Societe Generale. The company was maintained on Monday, September 11 by Cowen & Co. Mainfirst downgraded Novartis AG (NYSE:NVS) on Wednesday, October 28 to “Underperform” rating. Leerink Swann downgraded Novartis AG (NYSE:NVS) rating on Wednesday, March 23. Leerink Swann has “Market Perform” rating and $85 target. As per Tuesday, April 5, the company rating was initiated by Argus Research. The firm earned “Buy” rating on Monday, October 10 by Chardan Capital Markets. The rating was downgraded by Cowen & Co to “Market Perform” on Wednesday, April 5. The rating was downgraded by Citigroup on Tuesday, March 29 to “Neutral”.
More notable recent Novartis AG (NYSE:NVS) news were published by: Seekingalpha.com which released: “Novartis: Exit Sandoz US Now” on June 06, 2018, also Seekingalpha.com with their article: “Novartis’ Kymriah shows sustained benefit in DLBCL patients” published on June 18, 2018, Streetinsider.com published: “Novartis (NVS) Granted FDA Approval for Inclusion of New Evidence that Cosentyx (secukinumab) Inhibits Progression …” on June 19, 2018. More interesting news about Novartis AG (NYSE:NVS) were released by: Prnewswire.com and their article: “Developing Technologies for Optical Therapies Aimed At Overcoming Key Challenges in the Healthcare Industry” published on June 21, 2018 as well as Fool.com‘s news article titled: “5 Experimental New Drugs That Could Be Worth $47 Billion” with publication date: June 20, 2018.
More important recent UnitedHealth Group Incorporated (NYSE:UNH) news were published by: Seekingalpha.com which released: “UnitedHealth, Quest Diagnostics unveil strategic partnership” on May 24, 2018, also Fool.com published article titled: “The 6 Stocks on the MFM Team’s Radar This Week”, Benzinga.com published: “10 Biggest Price Target Changes For Thursday” on June 21, 2018. More interesting news about UnitedHealth Group Incorporated (NYSE:UNH) was released by: Businesswire.com and their article: “AM Best Upgrades Issuer Credit Ratings of UnitedHealth Group Incorporated and Its UnitedHealthcare Subsidiaries” with publication date: June 21, 2018.
Adams Express Company decreased Lowe’s Companies Inc. (NYSE:LOW) stake by 53,000 shares to 201,100 valued at $17.65M in 2018Q1. It also reduced Nextera Energy Inc. (NYSE:NEE) stake by 12,800 shares and now owns 99,000 shares. Boeing Company (NYSE:BA) was reduced too.
Among 27 analysts covering UnitedHealth Group (NYSE:UNH), 26 have Buy rating, 0 Sell and 1 Hold. Therefore 96% are positive. UnitedHealth Group had 91 analyst reports since September 2, 2015 according to SRatingsIntel. The rating was upgraded by Mizuho on Wednesday, November 30 to “Buy”. The rating was maintained by Cantor Fitzgerald with “Buy” on Monday, December 25. The company was maintained on Wednesday, June 21 by Jefferies. The firm has “Buy” rating given on Monday, August 21 by RBC Capital Markets. The firm has “Buy” rating by Deutsche Bank given on Thursday, July 13. The stock has “Buy” rating by Jefferies on Tuesday, November 28. UBS maintained the stock with “Buy” rating in Wednesday, July 19 report. On Wednesday, July 20 the stock rating was maintained by RBC Capital Markets with “Outperform”. On Wednesday, April 18 the stock rating was maintained by Credit Suisse with “Outperform”. The company was maintained on Wednesday, April 18 by Morgan Stanley.
Since January 18, 2018, it had 0 insider buys, and 13 insider sales for $36.37 million activity. Another trade for 14,233 shares valued at $3.28M was sold by Nelson Steven H. Another trade for 20,000 shares valued at $4.79 million was made by BURKE RICHARD T on Thursday, January 18. $5.00 million worth of UnitedHealth Group Incorporated (NYSE:UNH) was sold by RENFRO LARRY C on Friday, June 15. The insider WILENSKY GAIL R sold 5,820 shares worth $1.40 million. Shares for $48,025 were sold by Shine Kenneth Irwin. HOOPER MICHELE J had sold 10,000 shares worth $2.38 million. $2.46 million worth of stock was sold by BALLARD WILLIAM C JR on Tuesday, January 23.